Table 2. MD Anderson criteria for evaluation of response in bone metastases.
| Response type | Definition |
|---|---|
| Complete response | Complete fill-in or sclerosis of lytic lesion on CT or XR |
| Disappearance of tumor signal on bone scan, CT, or MRI | |
| Normalization of osteoblastic lesion on CT or XR | |
| Partial response | Sclerotic rim formation around initially lytic lesion on CT |
| Sclerosis of lesions previously undetected on CT or XR | |
| Partial fill-in or sclerosis of lytic lesion on CT or XR | |
| Regression of measurable lesion on CT, MRI, or XR | |
| Regression of lesion on bone scan | |
| Decrease in blastic lesion on CT or XR | |
| Stable disease | No change in measurable lesion on CT, MRI, or XR |
| No change in blastic or lytic lesion or CT, MRI, or XR | |
| No new lesion on CT, MRI, or XR | |
| Progressive disease | Increase in size of existing measurable lesion on CT, MRI, or XR |
| New lesion on CT, MRI, bone scan, or XR | |
| Increase in lytic or blastic lesion on CT or XR |
Ct, computed tomography; xr, plain radiography; Mri, magnetic resonance imaging. Adopted with publisher permission from (129).